Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAkyerli, Cemaliye B.
dc.contributor.authorYuksel, Sirin
dc.contributor.authorCan, Ozge
dc.contributor.authorErson\\-Omay, E. Zeynep
dc.contributor.authorOktay, Yavuz
dc.contributor.authorCosgun, Erdal
dc.contributor.authorUlgen, Ege
dc.contributor.authorErdemgil, Yigit
dc.contributor.authorSav, Aydin
dc.contributor.authorvon Deimling, Andreas
dc.contributor.authorGunel, Murat
dc.contributor.authorYakicier, M. Cengiz
dc.contributor.authorPamir, M. Necmettin
dc.contributor.authorOzduman, Koray
dc.date.accessioned2025-10-16T15:25:45Z
dc.date.issued2018
dc.identifier.doi10.3171/2016.11.JNS16973
dc.identifier.otherWOS:000429045500251
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8296
dc.publisherAMER ASSOC NEUROLOGICAL SURGEONS
dc.sourceJOURNAL OF NEUROSURGERY
dc.subjectglioma
dc.subjectisocitrate dehydrogenase
dc.subjecttelomerase
dc.subjectmutation
dc.subjectprognosis
dc.subjectoncology
dc.titleUse of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS